Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PH-797804 in Post-Herpetic Neuralgia
NCT00614705Phase 2Completed
- Sponsor
- Pfizer
- Start
- Apr 2008
- Primary completion
- Nov 2008
- Modality
- Classical Binding Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of PH-797804 in postherpetic neuralgia (PHN), sponsored by Pfizer. Started Apr 2008; status: completed.
02
Drugs
PH-797804
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00614705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00614705.